Darin Lippoldt, Chief Legal Officer at Neurocrine Biosciences, sold NBIX on Jun 29, 2026
Data as of Oct 16
- Traded
- Jun 29, 2026
- Disclosed
- Jun 30, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NBIX since disclosure
−19.5%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund
Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLDarin Lippoldt Chief Legal OfficerNBIX Neurocrine Biosciences Inc$1.4Mdisclosed Jun 30 · filed 1 day after the trade
- ▼ SELLDarin Lippoldt Chief Legal OfficerNBIX Neurocrine Biosciences Inc$33.9Kdisclosed Jun 30 · filed 4 days after the trade